Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.82 USD | -0.41% | -8.49% | -13.19% |
May. 09 | Stifel Adjusts Price Target on C4 Therapeutics to $14 From $13, Maintains Buy Rating | MT |
May. 08 | C4 Therapeutics Shares Decline as Q1 Revenue Misses Estimates | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.19% | 333M | |
+43.87% | 56.65B | |
-6.89% | 39.44B | |
+38.87% | 39.03B | |
-11.17% | 26.86B | |
+13.21% | 26.75B | |
-21.12% | 19.03B | |
+1.38% | 12.28B | |
+26.28% | 12.26B | |
+27.83% | 12.04B |
- Stock Market
- Equities
- CCCC Stock
- News C4 Therapeutics, Inc.
- Wells Fargo Adjusts Price Target on C4 Therapeutics to $11 From $12, Maintains Equal-Weight Rating